Phathom Pharmaceuticals
Phathom Pharmaceuticals is a novel treatments for gastrointestinal diseases and disorders founded in 2018 by Tachi Yamada, Aditya Kohli, David Socks and Azmi Nabulsi.
1
Funding Rounds
$140.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ta*** Ya**** | - | - | - |
| Ad**** Ko*** | - | - | - |
| Da*** So*** | - | - | - |
| Az** Na***** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Da*** So*** | - | - | - |
| Mi***** Co** | - | - | - |
| Te**** Cu**** | - | - | |
| Fr*** Ka*** | - | - | - |
| He*** Ku** | - | - | - |
| As** Pa**** | - | - | - |
| Ma** St******* | - | - | - |
Funding series
Funding Series Analysis
The company Phathom Pharmaceuticals has raised a total of $140m in funding over 1 rounds.
Key Insights:
- Phathom Pharmaceuticals , May 2019: $140m
Phathom Pharmaceuticals , May 2019
$140m
Industries
Phathom Pharmaceuticals is active in the following industries: